This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • HIV/AIDS  • Tuberculosis/ Other Mycobacterium  • Alert me on articles by topic

JAMA. 2007;298(23):2736-2737.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2007;56:1103-1106

1 figure, 2 tables omitted

Knowing the human immunodeficiency virus (HIV) status of tuberculosis (TB) patients is essential to optimal patient management. TB is an acquired immunodeficiency syndrome (AIDS)-defining opportunistic condition. Patients with both TB and HIV infection are five times more likely to die during anti-TB treatment than patients who are not HIV infected (CDC, unpublished data, 2003). HIV infection is the greatest known risk factor for progression from latent TB infection to TB disease.¹ In the United States, after TB exposure and infection, HIV-infected persons who do not receive appropriate treatment progress to TB disease over 5 years at a rate 10 times greater than that for persons not infected with HIV.^2,3 In 1989, CDC recommended that all TB patients be offered HIV testing⁴ and, in 2006, called for routine HIV screening of all TB patients after the patient is notified that testing will be performed, . . . [Full Text of this Article]

Reported by: